References
- Jansen T. Clinical presentations and classification of rosacea. Ann Dermatol Venereol 2011;138:192–200
- Schauber J, Gallo RL. The vitamin D pathway: a new target for control of the skin's immune response? Exp Dermatol 2008;17:633–639.
- Van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005;97:93–101
- Bikle DD. What is new in vitamin D: 2006–2007. Curr Opin Rheumatol 2007;19:383–388
- Antal AS, Dombrowski Y, Koglin S, et al. Impact of vitamin D3 on cutaneous immunity and antimicrobial peptide expression. Dermatoendocrinol 2011;3:18–22
- Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004;51:327–341
- Elsaie ML, Choudhary S. Updates on the pathophysiology and management of acne rosacea. Postgrad Med 2009;121:178–186
- Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–281
- Bartly J. Vitamin D: emerging roles in infection and immunity. Expert Rev Anti Infect Ther 2010;8:1359–1369
- Schauber J, Gallo RL. The vitamin D pathway: a new target for control of skin’s immune response? Exp Dermatol 2008;17:633–639.
- Gisondi P, Rossini M, Di Cesare A, et al. Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol 2012;166:505–510
- Peroni DG, Piacentini GL, Cametti E, et al. Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. Br J Dermatol 2011;164:1078–1082
- Thorp WA, Goldner W, Meza J, Poole JA. Reduced vitamin D levels in adult subjects with chronic urticaria. J Allergy Clin Immunol 2010;126:413
- Silverberg JI, Silverberg AI, Malka E, Silverberg NB. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J Am Acad Dermatol 2010;62:937–941
- Xu X, Fu WW, Wu WY. Serum 25-hydroxyvitamin D deficiency in chinese patients with vitiligo: a case-control study. PLoS One 2012;7:e52778
- Hata TR, Kotol P, Jackson M, et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy ClinImmunol 2008;122:829–831
- Schauber J. Antimicrobial peptides, vitamin D and more. How rosacea may develop. Hautarzt 2011;62:815–819
- Bagot M, Chaure D, Lesc MC, et al. Immunosupressive effects of 1,25-dihidrokxyvitamin D3 and its analogue caciportriol on epidermal cells. Br J Dermatol 1994;130:424–431
- Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 2008;122:261–266
- Murakami M, Dorschner RA, Stern LJ, et al. Expression and secretion of cathelicidin antimicrobial peptides in murine mammary glands and human milk. Pediatr Res 2005;57:10–15
- Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007;13:975–980
- Hekimsoy Z, Dinç G, Kafesçiler S, et al. Vitamin D status among adults in the Aegean region of Turkey. BMC Public Health 2010;10:782